Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octenidine Mouthwash for Plaque Inhibition
NCT03322124Phase 3Completed
- Sponsor
- Schülke & Mayr
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of octenidine in dental plaque, sponsored by Schülke & Mayr. Started Jan 2018; status: completed.
02
Drugs
octenidine
03
Conditions
dental plaque
Beyond the preview
Go deeper on NCT03322124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03322124.